Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine vs Bupivacaine in Deep Topical Fornix Nerve Block for Cataract Surgery
NCT02925832Completed
- Sponsor
- Government Medical College, Haldwani
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in cataract comparing Group B (Bupivacaine) with Group R (Ropivacaine) (2 arms). Primary endpoint: Level of pain and discomfort during surgery at 1 hour. Started Oct 2016; status: completed.
02
Drugs
ropivacainebupivacaine
03
Conditions
cataract
Beyond the preview
Go deeper on NCT02925832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02925832.